Overview

Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen

Status:
Completed

Trial end date:
2021-04-30

Target enrollment:

Participant gender:

Summary

The study compares two lengths of medication therapy (a shortened versus a prolonged dual antiplatelet therapy) in order to prevent thrombus (blood cloth) formation after the successfully treatment for coronary heart disease with a drug covered stent (metallic tube). This comparison will be done in patients who, compared to the average patient, are more likely to suffer from complications on antiplatelet therapy (bleeding). Both durations are within the current medical recommendations. The aim of this study is to help improve further standard antiplatelet duration guidelines.

Phase:

N/A

Details

Lead Sponsor:

ECRI bv

Collaborators:

Cardialysis B.V.
European Cardiovascular Research Center
Terumo Medical Corporation
University of Bern

Treatments:

Aspirin
Clopidogrel
Platelet Aggregation Inhibitors